Skip to content

Clinical trials

Phase 2 Renal Insufficiency, Chronic trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Renal Insufficiency, Chronic Phase: Phase 2 Country / region: United States Clear all

155 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20031
20041
20053
20067
20072
20083
20099
20109
20115
20128
20138
20145
20154
201610
20174
201810
20199
20203
202113
202211
20239
20247
20254
20268

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed103
Terminated18
Recruiting15
Withdrawn5
Not yet recruiting4
Unknown status4
Active, not recruiting3
Enrolling by invitation2
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Akebia Therapeutics7
AstraZeneca7
GlaxoSmithKline7
Bayer5
Boehringer Ingelheim5
Genzyme, a Sanofi Company5
VA Office of Research and Development5
Eli Lilly and Company4
Kyntra Bio4
Novartis Pharmaceuticals4

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Renal Insufficiency, Chronic155
Anemia26
Diabetes Mellitus, Type 216
Diabetic Nephropathies15
Hypertension12
Kidney Diseases12
Kidney Failure, Chronic12
Renal Insufficiency9
Cardiovascular Diseases8
Proteinuria8

Trials

Showing 1 to 25 of 155. Each trial links to its page on Pharma Observatory.

55 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.